In another study [61], the effects of MB were compared to donepezil in patients with Alzheimer’s disease (diagnosis confirmation by magnetic resonance imaging of the brain, brain tomography, and evaluation of cerebrospinal fluid biomarkers, such as β amyloid and total tau). This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.